nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—YWHAG—forebrain—attention deficit hyperactivity disorder	0.034	0.0533	CbGeAlD
Daunorubicin—TOP2B—forebrain—attention deficit hyperactivity disorder	0.0327	0.0514	CbGeAlD
Daunorubicin—ABCC6—cardiovascular system—attention deficit hyperactivity disorder	0.0305	0.0479	CbGeAlD
Daunorubicin—YWHAG—cardiovascular system—attention deficit hyperactivity disorder	0.0287	0.0451	CbGeAlD
Daunorubicin—NR5A1—nervous system—attention deficit hyperactivity disorder	0.0279	0.0438	CbGeAlD
Daunorubicin—TOP2B—cardiovascular system—attention deficit hyperactivity disorder	0.0277	0.0435	CbGeAlD
Daunorubicin—NR5A1—central nervous system—attention deficit hyperactivity disorder	0.0269	0.0422	CbGeAlD
Daunorubicin—NR5A1—cerebellum—attention deficit hyperactivity disorder	0.0263	0.0412	CbGeAlD
Daunorubicin—YWHAG—midbrain—attention deficit hyperactivity disorder	0.0224	0.0352	CbGeAlD
Daunorubicin—TOP2B—midbrain—attention deficit hyperactivity disorder	0.0216	0.0339	CbGeAlD
Daunorubicin—NR5A1—brain—attention deficit hyperactivity disorder	0.0213	0.0335	CbGeAlD
Daunorubicin—YWHAG—nervous system—attention deficit hyperactivity disorder	0.0184	0.029	CbGeAlD
Daunorubicin—TOP2B—nervous system—attention deficit hyperactivity disorder	0.0178	0.0279	CbGeAlD
Daunorubicin—YWHAG—central nervous system—attention deficit hyperactivity disorder	0.0178	0.0279	CbGeAlD
Daunorubicin—YWHAG—cerebellum—attention deficit hyperactivity disorder	0.0174	0.0272	CbGeAlD
Daunorubicin—TOP2B—central nervous system—attention deficit hyperactivity disorder	0.0171	0.0269	CbGeAlD
Daunorubicin—POR—midbrain—attention deficit hyperactivity disorder	0.0171	0.0268	CbGeAlD
Daunorubicin—TOP2B—cerebellum—attention deficit hyperactivity disorder	0.0167	0.0263	CbGeAlD
Daunorubicin—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.0148	0.0408	CbGpPWpGaD
Daunorubicin—YWHAG—brain—attention deficit hyperactivity disorder	0.0141	0.0221	CbGeAlD
Daunorubicin—CYP1B1—cardiovascular system—attention deficit hyperactivity disorder	0.0136	0.0214	CbGeAlD
Daunorubicin—TOP2B—brain—attention deficit hyperactivity disorder	0.0136	0.0213	CbGeAlD
Daunorubicin—ABCC10—midbrain—attention deficit hyperactivity disorder	0.0135	0.0212	CbGeAlD
Daunorubicin—POR—cerebellum—attention deficit hyperactivity disorder	0.0132	0.0207	CbGeAlD
Daunorubicin—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0126	0.0347	CbGpPWpGaD
Daunorubicin—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0125	0.0344	CbGpPWpGaD
Daunorubicin—POR—brain—attention deficit hyperactivity disorder	0.0107	0.0168	CbGeAlD
Daunorubicin—ABCC10—cerebellum—attention deficit hyperactivity disorder	0.0105	0.0164	CbGeAlD
Daunorubicin—XDH—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00901	0.0248	CbGpPWpGaD
Daunorubicin—CYP1B1—nervous system—attention deficit hyperactivity disorder	0.00875	0.0137	CbGeAlD
Daunorubicin—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00869	0.0239	CbGpPWpGaD
Daunorubicin—ABCC10—brain—attention deficit hyperactivity disorder	0.00851	0.0134	CbGeAlD
Daunorubicin—CYP1B1—central nervous system—attention deficit hyperactivity disorder	0.00842	0.0132	CbGeAlD
Daunorubicin—CYP1B1—cerebellum—attention deficit hyperactivity disorder	0.00823	0.0129	CbGeAlD
Daunorubicin—YWHAG—Membrane Trafficking—SNAP23—attention deficit hyperactivity disorder	0.00801	0.0221	CbGpPWpGaD
Daunorubicin—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00793	0.0124	CbGeAlD
Daunorubicin—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.00741	0.0204	CbGpPWpGaD
Daunorubicin—ABCC1—cerebellum—attention deficit hyperactivity disorder	0.00741	0.0116	CbGeAlD
Daunorubicin—CYP1B1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00731	0.0201	CbGpPWpGaD
Daunorubicin—XDH—Nucleotide metabolism—DPYD—attention deficit hyperactivity disorder	0.00686	0.0189	CbGpPWpGaD
Daunorubicin—CYP1B1—brain—attention deficit hyperactivity disorder	0.00669	0.0105	CbGeAlD
Daunorubicin—ABCG2—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.00665	0.0183	CbGpPWpGaD
Daunorubicin—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00654	0.018	CbGpPWpGaD
Daunorubicin—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.00619	0.00971	CbGeAlD
Daunorubicin—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00613	0.00963	CbGeAlD
Daunorubicin—ABCC1—brain—attention deficit hyperactivity disorder	0.00602	0.00944	CbGeAlD
Daunorubicin—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00596	0.00935	CbGeAlD
Daunorubicin—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00592	0.00929	CbGeAlD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00578	0.0159	CbGpPWpGaD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00551	0.0152	CbGpPWpGaD
Daunorubicin—SLC22A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.00514	0.0142	CbGpPWpGaD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00505	0.0139	CbGpPWpGaD
Daunorubicin—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.005	0.00786	CbGeAlD
Daunorubicin—ABCG2—brain—attention deficit hyperactivity disorder	0.00498	0.00782	CbGeAlD
Daunorubicin—CYP1B1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00496	0.0137	CbGpPWpGaD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00482	0.0133	CbGpPWpGaD
Daunorubicin—CYP1A1—brain—attention deficit hyperactivity disorder	0.00473	0.00742	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00463	0.0127	CbGpPWpGaD
Daunorubicin—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.00459	0.0127	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00458	0.0126	CbGpPWpGaD
Daunorubicin—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00454	0.00713	CbGeAlD
Daunorubicin—CYP1A1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0045	0.0124	CbGpPWpGaD
Daunorubicin—SLC22A2—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.00441	0.0121	CbGpPWpGaD
Daunorubicin—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00437	0.00686	CbGeAlD
Daunorubicin—YWHAG—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00435	0.012	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00394	0.0108	CbGpPWpGaD
Daunorubicin—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00391	0.00614	CbGeAlD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00366	0.0101	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00366	0.0101	CbGpPWpGaD
Daunorubicin—SLC22A2—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00332	0.00914	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00326	0.00898	CbGpPWpGaD
Daunorubicin—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00321	0.00504	CbGeAlD
Daunorubicin—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00309	0.00486	CbGeAlD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00309	0.00852	CbGpPWpGaD
Daunorubicin—CYP1A1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00305	0.00841	CbGpPWpGaD
Daunorubicin—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00302	0.00475	CbGeAlD
Daunorubicin—YWHAG—FoxO family signaling—EP300—attention deficit hyperactivity disorder	0.00301	0.00828	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00298	0.00821	CbGpPWpGaD
Daunorubicin—CYP1A1—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00297	0.00818	CbGpPWpGaD
Daunorubicin—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00287	0.00791	CbGpPWpGaD
Daunorubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—attention deficit hyperactivity disorder	0.00278	0.00766	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00276	0.00759	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00269	0.0074	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00266	0.00732	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00263	0.00724	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.00262	0.0072	CbGpPWpGaD
Daunorubicin—ABCB1—brain—attention deficit hyperactivity disorder	0.00246	0.00386	CbGeAlD
Daunorubicin—SLC22A2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00237	0.00653	CbGpPWpGaD
Daunorubicin—CYP1B1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00225	0.00619	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00225	0.00619	CbGpPWpGaD
Daunorubicin—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00222	0.0061	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.00213	0.00587	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00209	0.00576	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00209	0.00576	CbGpPWpGaD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—attention deficit hyperactivity disorder	0.00203	0.00559	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00202	0.00558	CbGpPWpGaD
Daunorubicin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00201	0.00554	CbGpPWpGaD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00201	0.00554	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00197	0.00541	CbGpPWpGaD
Daunorubicin—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00195	0.00536	CbGpPWpGaD
Daunorubicin—ABCC2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00189	0.00521	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—SYNE1—attention deficit hyperactivity disorder	0.00188	0.00517	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00183	0.00504	CbGpPWpGaD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00176	0.00484	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00171	0.00472	CbGpPWpGaD
Daunorubicin—ABCC2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00169	0.00464	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.00167	0.0046	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00158	0.00436	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00158	0.00436	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00155	0.00427	CbGpPWpGaD
Daunorubicin—YWHAG—G2/M Transition—EP300—attention deficit hyperactivity disorder	0.00154	0.00424	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00153	0.00422	CbGpPWpGaD
Daunorubicin—YWHAG—Mitotic G2-G2/M phases—EP300—attention deficit hyperactivity disorder	0.00152	0.00418	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00148	0.00408	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00148	0.00408	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00148	0.00408	CbGpPWpGaD
Daunorubicin—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00146	0.00403	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00146	0.00403	CbGpPWpGaD
Daunorubicin—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00138	0.00381	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00136	0.00375	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00135	0.00372	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00134	0.00368	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00129	0.00354	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00127	0.00351	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00127	0.00349	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00121	0.00334	CbGpPWpGaD
Daunorubicin—CYP1B1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0012	0.00331	CbGpPWpGaD
Daunorubicin—CYP1B1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00119	0.00329	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00119	0.00328	CbGpPWpGaD
Daunorubicin—CYP1B1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00119	0.00326	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00113	0.00311	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00104	0.00287	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00101	0.00278	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000969	0.00267	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000959	0.00264	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000952	0.00262	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000917	0.00253	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000914	0.00252	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000911	0.00251	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000911	0.00251	CbGpPWpGaD
Daunorubicin—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000882	0.00243	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000864	0.00238	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000847	0.00233	CbGpPWpGaD
Daunorubicin—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000807	0.00222	CbGpPWpGaD
Daunorubicin—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000783	0.00216	CbGpPWpGaD
Daunorubicin—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000778	0.00214	CbGpPWpGaD
Daunorubicin—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000772	0.00213	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00074	0.00204	CbGpPWpGaD
Daunorubicin—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000735	0.00202	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000735	0.00202	CbGpPWpGaD
Daunorubicin—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00073	0.00201	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00073	0.00201	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000729	0.00201	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000708	0.00195	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STUB1—attention deficit hyperactivity disorder	0.000706	0.00194	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000696	0.00192	CbGpPWpGaD
Daunorubicin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000681	0.00187	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00068	0.00187	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000676	0.00186	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000633	0.00174	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000633	0.00174	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000623	0.00172	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000581	0.0016	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000581	0.0016	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000579	0.0016	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000545	0.0015	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00054	0.00149	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000533	0.00147	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000521	0.00143	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000508	0.0014	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000506	0.00139	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000491	0.00135	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.00049	0.00135	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000482	0.00133	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000472	0.0013	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000469	0.00129	CbGpPWpGaD
Daunorubicin—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000468	0.00129	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000467	0.00129	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000467	0.00129	CbGpPWpGaD
Daunorubicin—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000465	0.00128	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000465	0.00128	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000459	0.00126	CbGpPWpGaD
Daunorubicin—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000454	0.00125	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000447	0.00123	CbGpPWpGaD
Daunorubicin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000444	0.00122	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000442	0.00122	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000438	0.00121	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000427	0.00118	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—COMT—attention deficit hyperactivity disorder	0.000384	0.00106	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000381	0.00105	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000373	0.00103	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000364	0.001	CbGpPWpGaD
Daunorubicin—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000362	0.000996	CbGpPWpGaD
Daunorubicin—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000359	0.000989	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000355	0.000979	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000351	0.000966	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000351	0.000966	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000345	0.00095	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000343	0.000944	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000339	0.000934	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000339	0.000934	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000335	0.000922	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000334	0.000919	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000321	0.000883	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00032	0.000882	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00031	0.000854	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000309	0.00085	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000309	0.00085	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000306	0.000844	CbGpPWpGaD
Daunorubicin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000306	0.000843	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000305	0.000841	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000305	0.000841	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000304	0.000836	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000303	0.000834	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.0003	0.000828	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—COMT—attention deficit hyperactivity disorder	0.000283	0.000779	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000282	0.000777	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000281	0.000774	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00028	0.000772	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000279	0.000769	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000272	0.00075	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000271	0.000747	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000267	0.000735	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000258	0.000711	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000254	0.000699	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000247	0.000679	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000244	0.000672	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000242	0.000666	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000235	0.000647	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000233	0.000642	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000232	0.00064	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000221	0.000609	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000221	0.000609	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000218	0.000599	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000212	0.000585	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000211	0.000581	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000209	0.000575	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000209	0.000575	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000205	0.000566	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000205	0.000566	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000205	0.000564	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000204	0.000562	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000202	0.000557	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000198	0.000545	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000193	0.000531	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000191	0.000526	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000187	0.000515	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000186	0.000511	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000185	0.00051	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000184	0.000506	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000177	0.000487	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000168	0.000463	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000167	0.00046	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000167	0.00046	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000167	0.00046	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—EP300—attention deficit hyperactivity disorder	0.000165	0.000453	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000164	0.000452	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000159	0.000438	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000153	0.00042	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000149	0.00041	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.000134	0.000369	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000133	0.000367	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000133	0.000367	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000133	0.000367	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000133	0.000366	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000131	0.000361	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000127	0.00035	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000127	0.000349	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000126	0.000346	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000122	0.000336	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000122	0.000336	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—EP300—attention deficit hyperactivity disorder	0.000121	0.000334	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EP300—attention deficit hyperactivity disorder	0.000109	0.0003	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000106	0.000293	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000103	0.000283	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000103	0.000283	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000101	0.000279	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000101	0.000279	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000101	0.000278	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.0001	0.000276	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.4e-05	0.000259	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—EP300—attention deficit hyperactivity disorder	9.11e-05	0.000251	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—EP300—attention deficit hyperactivity disorder	8.81e-05	0.000243	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.22e-05	0.000226	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	8.07e-05	0.000222	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	8.02e-05	0.000221	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	8.01e-05	0.000221	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	7.93e-05	0.000219	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.82e-05	0.000215	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.77e-05	0.000214	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	6.23e-05	0.000172	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	6.18e-05	0.00017	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	5.74e-05	0.000158	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	5.43e-05	0.000149	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	4.33e-05	0.000119	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	3.46e-05	9.53e-05	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.67e-05	7.36e-05	CbGpPWpGaD
